important determinant success new therapy ability deliver molecules target cells organ selective delivery complex therapeutic agents peptides modified oligonucleotides genes paper summarize possibility using autologous erythrocytes delivery targeting new conventional therapeutics fact number macromolecules encapsulated different procedures human erythrocytes modified cells compatible recipient circulate weeks erythrocytes modified selectively recognized tissue macrophages phagocyte cells recognize modified erythrocytes able release content macrophage feasibility safety use erythrocytes drug delivery systems evaluated NUMBER cystic fibrosis patients sustained release corticosteroids dexamethasone erythrocytes obtained vitro human erythrocytes able deliver ubiquitin analogues modified oligonucleotides macrophages erythrocytes safe useful carriers new conventional therapeutics advantageous delivery systems new clinical applications proteins oligonucleotides therapeutic agents infused drug loaded drug loaded NUMBER phosphate loaded drug loaded